TIM‑4 Blockade of KCs Combined with Exogenous TGF‑β Injection Helps to Reverse Acute Rejection and Prolong the Survival Rate of Mice Receiving Liver Allografts.

Hao Wu,Xuesong Xu,Jinzheng Li,Jianping Gong,Min Li
DOI: https://doi.org/10.3892/ijmm.2018.3606
IF: 5.314
2018-01-01
International Journal of Molecular Medicine
Abstract:An acute reaction response (AR) following liver transplantation (LT) is caused by immune responses that are primarily mediated by T lymphocytes. Kupffer cells (KCs) are the largest antigen presenting cell (APC) group in vivo and are the primary modulators of the inflammatory or tolerogenic immune response in liver tissues. T cell immunoglobulin-domain and mucin-domain-4 (TIM-4), the only TIM protein not expressed on T cells, is expressed on APCs; suggesting that it mediates the various immune responses. However, to the best of our knowledge, the role of TIM-4 expressed by KCs in LT injury remains unknown. The present study aimed to explore whether and how TIM-4 expressed by KCs is involved in the AR of liver allografts. Orthotopic liver transplantation (OLT) was performed in mice to establish a model of AR and results demonstrated that LT may lead to the augmented expression of TIM-4 in activated KCs. It was also revealed that TIM-4 blockade markedly attenuated AR injury in vivo via the nuclear factor-B (NF-B) and p38 mitogen-activated protein kinase (p38 MAPK) signaling pathways. In addition, levels of transforming growth factor- (TGF-) were increased following TIM-4 blockade. Furthermore, in a KC/cluster of differentiation (CD)4(+) T cell co-culture system, blocking TIM-4 inhibited T helper 2 (Th2) differentiation, stimulated the conversion of naive (CD)4(+) T cells into CD4(+)CD25(+)Forkhead box protein p3(+) T regulatory cells and suppressed interleukin-4/signal transducer and activator of transcription 6/transcription factor gata3 signaling. These effects were enhanced following the addition of TGF-. It was also demonstrated that LT mouse models treated with TIM-4 blockade in combination with exogenous TGF- injections, increased the survival times of mice and enhanced the amelioration of AR in LT. These results indicate that blocking the expression of TIM-4 by KCs via exogenous TGF- injection may be an effective therapeutic strategy to inhibit the AR of liver allografts.
What problem does this paper attempt to address?